References
- Sabatelli M, Madia F, Conte A, Luigetti M, Zollino M, Mancuso I, et al. Natural history of young-adult amyotrophic lateral sclerosis. Neurology. 2008; 71:876–81.
- Orban P, Devon R, Hayden M, Leavitt B. Juvenile amyotrophic lateral sclerosis. Handbook Clin Neurol. 2007;82:302–12.
- Hübers A, Just W, Rosenbohm A, Müller K, Marroquin N, Goebel I, et al. De novo FUS mutations are the most frequent genetic cause in early-onset German ALS patients. Neurobiol Aging. 2015;36:3117e1–6.
- Logroscino G, Traynor BJ, Hardiman O, Chiò A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385–90.
- Zou Z, Liu M, Li X, Cui L. Mutations in SOD1 and FUS caused juvenile-onset sporadic amyotrophic lateral sclerosis with aggressive progression. Ann Transl Med. 2015;3:221.
- Orlacchio A, Babalini C, Borreca A, Patrono C, Massa R, Basaran S, et al. Spatacsin mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis. Brain. 2010;133:591–8.
- Millecamps S, Salachas F, Cazeneuve C, Gordon PH, Bricka B, Camuzat A, et al. SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations. J Med Genet. 2010;48:554–60.
- Leblond C, Webber A, Gan-Or Z, Moore F, Dagher A, Dion P, et al. De novo FUS P525L mutation in juvenile amyotrophic lateral sclerosis with dysphonia and diplopia. Neurol Genet. 2016;2:e63.
- Niu C, Zhang J, Gao F, Yang L, Jia M, Zhu H, et al. FUS-NLS/Transportin 1 complex structure provides insights into the nuclear targeting mechanism of FUS and the implications in ALS. PLoS One. 2012;7:e47056.
- Mackenzie IR, Ansorge O, Strong M, Bilbao J, Zinman L, Ang LC, et al. Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutation. Acta Neuropathol. 2011;122:87–98.